JPRN-UMIN000014105已完成未知
Registry focused on very early presentation and treatment in emergency department of acute heart failure syndrome - REALITY-AHF
-40 HF Network0 个研究点目标入组 2,000 人开始时间: 2014年5月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. After cardiac transplantation 2. Chronic hemodialysis 3. Acute myocarditis 4. Acute coronary syndrome require emergent revascularization 5. BNP level < 100 pg/mL or N-terminal-proBNP level < 300 pg/mL at baseline
研究者
相似试验
已完成
1 期
Clinical study to check the safety and tolerability of ATRICOV 452 capsule of 500 mg in healthy adult human subjects.CTRI/2020/09/027660Atrimed Pharmaceutical Pvt Ltd24
撤回
不适用
Phase I, international, multicentre, open-label, non-randomised, non-comparative study of intravenously administered S64315, a Mcl1-inhibitor, in patients with Acute Myeloid Leukaemia (AML) or Myelodysplastic Syndrome (MDS)NL-OMON48784Servier R&D Benelux8
招募中
不适用
on-interventional, Prospective register concerning treatment of cervical cancer FIGO IB - IIA by nerve-sparing total mesometrial resection and therapeutic lymphadenectomy (TMMR/tLNE) according to M. Hoeckel.C53Malignant neoplasm of cervix uteriDRKS00004793niversitätsklinikum Essen300
尚未招募
1 期
Phase I open-label, age de-escalation trial to assess safety, tolerability, and immunogenicity of the intramuscularly administered combination of RH5.1 and R78C malaria vaccine with Matrix-MTM adjuvant in healthy adults and infants in Tanzania.MalariaPACTR202407803870883Ifakara Health Institute60
招募中
不适用
Prospective registration program / central review of morphologic diagnosis / follow-up study / genomic research for aplastic anemia and myelodysplastic syndromes.Aplastic anemia (AA) Myelodysplastic syndromes (MDS)JPRN-UMIN000043704Ministry of Health, Labor and Welfare (MHLW)500